| Literature DB >> 32597748 |
Kendrew S K Wong1, Suk Dhaliwal2, Jennifer Bilawka3, Jocelyn A Srigley4, Sylvie Champagne4,3, Marc G Romney4,3, Peter Tilley4, Manish Sadarangani5,6, James E A Zlosnik6, Mark A Chilvers1.
Abstract
Introduction. Burkholderia cepacia complex (Bcc) bacteria, currently consisting of 23 closely related species, and Burkholderia gladioli, can cause serious and difficult-to-treat infections in people with cystic fibrosis. Identifying Burkholderia bacteria to the species level is considered important for understanding epidemiology and infection control, and predicting clinical outcomes. Matrix-assisted laser desorption/ionization time-of-flight MS (MALDI-TOF) is a rapid method recently introduced in clinical laboratories for bacterial species-level identification. However, reports on the ability of MALDI-TOF to accurately identify Bcc to the species level are mixed.Aim. The aim of this project was to evaluate the accuracy of MALDI-TOF using the Biotyper and VITEK MS systems in identifying isolates from 22 different Bcc species and B. gladioli compared to recA gene sequencing, which is considered the current gold standard for Bcc.Methodology. To capture maximum intra-species variation, phylogenetic trees were constructed from concatenated multi-locus sequence typing alleles and clustered with a novel k-medoids approach. One hundred isolates representing 22 Bcc species, plus B. gladioli, were assessed for bacterial identifications using the two MALDI-TOF systems.Results. At the genus level, 100 and 97.0 % of isolates were confidently identified as Burkholderia by the Biotyper and VITEK MS systems, respectively; moreover, 26.0 and 67.0 % of the isolates were correctly identified to the species level, respectively. In many, but not all, cases of species misidentification or failed identification, a representative library for that species was lacking.Conclusion. Currently available MALDI-TOF systems frequently do not accurately identify Bcc bacteria to the species level.Entities:
Keywords: Bacterial identification; Burkholderia cepacia complex; Burkholderia gladioli; MALDI-TOF; cystic fibrosis
Mesh:
Substances:
Year: 2020 PMID: 32597748 PMCID: PMC7642978 DOI: 10.1099/jmm.0.001223
Source DB: PubMed Journal: J Med Microbiol ISSN: 0022-2615 Impact factor: 2.472
Fig. 1.K-medoids cluster plot for Burkholderia cepacia sensu stricto. Isolates were obtained from the PubMLST database, whereby MLST sequences were aligned using MAFFT, inputted into RAxML at 100 bootstraps and analysed for branch length distances using distTips. Distances were used to aggregate the isolates at k=6, which was determined through the optimal k-clusters using the elbow method. Numbers displayed represent the PubMLST ID for an isolate. Red dots represent the isolates selected as genetic representatives from each cluster.
Fig. 2.Clustered phylogenetic tree for . Isolates were obtained from the PubMLST database, whereby MLST sequences were aligned using MAFFT, inputted into RAxML at 100 bootstraps and analysed for branch length distances using distTips. Distances were used to aggregate the isolates at k=6, which was determined through the optimal k-clusters using the elbow method. Isolates are coloured according to their cluster and were visualized on ggtree. Red arrows and numbers denote the isolates selected from each cluster as a genetic representative. The first number listed in annotations is the isolate's respective PubMLST ID. Scale bar represents substitutions per site
Comparison of identification results from MALDI-TOF using Biotyper, VITEK and recA sequencing
|
|
No. of isolates |
MALDI-TOF identification | |||
|---|---|---|---|---|---|
|
Biotyper |
VITEK | ||||
|
Genus-level concordance (%) |
Species-level concordance (%) |
Genus-level concordance (%) |
Species-level concordance (%) | ||
|
|
4 |
100 |
25 |
100 |
75 |
|
|
4 |
100 |
25 |
100 |
100 |
|
|
4 |
100 |
0 |
100 |
100 |
|
|
5 |
100 |
40 |
100 |
100 |
|
|
5 |
100 |
60 |
80 |
80 |
|
|
5 |
100 |
0 |
100 |
80 |
|
|
5 |
100 |
0 |
100 |
40 |
|
|
5 |
100 |
20 |
100 |
60 |
|
|
5 |
100 |
100 |
100 |
80 |
|
|
5 |
100 |
100 |
100 |
100 |
|
|
5 |
100 |
0 |
100 |
60 |
|
|
4 |
100 |
25 |
100 |
100 |
|
|
4 |
100 |
0 |
100 |
25 |
|
|
5 |
100 |
80 |
100 |
100 |
|
|
1 |
100 |
0 |
100 |
0 |
|
|
4 |
100 |
0 |
50 |
0 |
|
|
1 |
100 |
0 |
100 |
0 |
|
|
5 |
100 |
0 |
100 |
80 |
|
|
4 |
100 |
0 |
100 |
0 |
|
|
5 |
100 |
0 |
100 |
100 |
|
|
4 |
100 |
0 |
100 |
0 |
|
|
4 |
100 |
0 |
100 |
0 |
|
|
2 |
100 |
0 |
100 |
100 |
|
|
5 |
100 |
60 |
100 |
100 |
|
Concordance for all isolates |
100.0 |
26.0 |
97.0 |
67.0 | |
|
Concordance for isolates with reference spectra |
100.0 |
34.7 |
99.0 |
81.7 | |
*Species lacking reference spectra on the Bruker Daltonics Biotyper system.
†Species lacking reference spectra on the bioMérieux VITEK MS system.
Comparison of confident identifications generated by MALDI-TOF using the Biotyper and VITEK systems to recA sequencing
|
Species, as identified by MALDI-TOF |
Biotyper |
VITEK | ||||
|---|---|---|---|---|---|---|
|
No. of isolates confidently identified |
Species-level concordance to |
Correct identity of misidentifications |
No. of isolates confidently identified |
Species-level concordance to |
Correct identity of misidentifications | |
|
|
1 |
100 |
– |
4 |
75 |
|
|
|
1 |
100 |
– |
4 |
100 |
– |
|
|
0 |
– |
– |
4 |
100 |
– |
|
|
5 |
100 |
– |
10 |
90 |
|
|
|
2 |
0 |
|
10 |
40 |
|
|
|
0 |
– |
– |
2 |
100 |
– |
|
|
1 |
100 |
– |
3 |
100 |
– |
|
|
5 |
100 |
– |
4 |
100 |
– |
|
|
5 |
100 |
– |
6 |
83.3 |
|
|
|
0 |
– |
– |
3 |
100 |
– |
|
|
1 |
100 |
– |
4 |
100 |
– |
|
|
0 |
– |
– |
1 |
100 |
– |
|
|
4 |
100 |
– |
5 |
100 |
– |
|
|
0 |
– |
– |
0 |
– |
– |
|
|
0 |
– |
– |
0 |
– |
– |
|
|
0 |
– |
– |
0 |
– |
– |
|
|
0 |
– |
– |
4 |
100 |
– |
|
|
0 |
– |
– |
0 |
– |
– |
|
|
0 |
– |
– |
5 |
100 |
– |
|
|
0 |
– |
– |
0 |
– |
– |
|
|
0 |
– |
– |
0 |
– |
– |
|
|
0 |
– |
– |
2 |
100 |
– |
|
|
3 |
100 |
– |
6 |
83.3 |
|
|
Concordance for all isolates (%) |
28 |
92.9 |
77 |
87.0 | ||
*Species lacking reference spectra on the Bruker Daltonics Biotyper system.
†Species lacking reference spectra on the bioMérieux VITEK MS system. Confident identifications are as defined by manufacturer guidelines outlined in the Methods.